Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 2/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7080172 | 0.97 | ALDH1A1 (0.39) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL7968390 | 0.79 | FFAR3 (0.38) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL17375325 | 0.78 | KDM4E (0.36) | FFAR3 | |
| SCHEMBL12676103 | 0.78 | ALDH1A1 (0.37) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL12883183 | 0.77 | ALDH1A1 (0.39) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL22550126 | 0.77 | ALDH1A1 (0.39) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL7080167 | 0.77 | ALDH1A1 (0.39) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL9681654 | 0.77 | FFAR3 (0.36) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL3909314 | 0.77 | FFAR3 (0.36) | FFAR3ALDH1A1SMN1; SMN2HSD11B1CETP | |
| SCHEMBL11923799 | 0.77 | SCN1A (0.35) | FFAR3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
| EP-0363223-A2 | 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | Sankyo Company Limited (JP) | 1990-04-11 | — | — | EP | disclosed |